S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mast Therapeutics Provides Update On Epic Study Enrollment And 2015 Milestones (2015/1/5)|
|Mast Therapeutics To Host Corporate Conference Call (2014/12/30)|
|Mast Therapeutics To Present At 2015 Biotech Showcase Conference On January 12th (2015/1/7)|
|Mast Therapeutics To Present At 17th Annual BIO CEO & Investor Conference On February 9th (2015/2/3)|
|Mast Announces Plans For Development Of Vepoloxamer (MST-188) In Heart Failure (2014/12/9)|
|Mast Therapeutics Announces Management Change (2015/1/24)|
|Mast Therapeutics Announces Initiation Of Phase 2a Studies Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (2015/2/4)|
|Mast Therapeutics To Present At Cowen And Company's 35th Annual Healthcare Conference On March 2nd (2015/2/24)|
|Mast Therapeutics Announces New Data Supporting Vepoloxamer In Embolic Stroke (2015/2/11)|
|ImmuCell Announces Financial Results for 2014 (2015/2/11)|
Click above to view more mutual fund data and stats for mast - Master Silicon Carbide Industries Inc.